Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification

被引:121
作者
Dias, Wagner B. [1 ]
Cheung, Win D. [1 ]
Wang, Zihao [1 ]
Hart, Gerald W. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
LINKED N-ACETYLGLUCOSAMINE; PROTEIN-KINASE; NUCLEOCYTOPLASMIC PROTEINS; TETRATRICOPEPTIDE REPEATS; SIGNALING COMPLEX; POSTTRANSLATIONAL MODIFICATIONS; SUBSTRATE-SPECIFICITY; DYNAMIC GLYCOSYLATION; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS;
D O I
10.1074/jbc.M109.007310
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Similar to phosphorylation, GlcNAcylation (the addition of O-GlcNAc to Ser(Thr) residues on polypeptides) is an abundant, dynamic, and inducible post-translational modification. Glc-NAcylated proteins are crucial in regulating virtually all cellular processes, including signaling, cell cycle, and transcription. Here we show that calcium/calmodulin-dependent kinase IV (CaMKIV) is highly GlcNAcylated in vivo. In addition, we show that upon activation of HEK293 cells, hemagglutinin-tagged CaMKIV GlcNAcylation rapidly decreases, in a manner directly opposing its phosphorylation at Thr-200. Correspondingly, there is an increase in CaMKIV interaction with O-GlcNAcase during CaMKIV activation. Furthermore, we identify at least five sites of GlcNAcylation on CaMKIV. Using site-directed mutagenesis, we determine that the GlcNAcylation sites located in the active site of CaMKIV can modulate its phosphorylation at Thr-200 and its activity toward cAMP-response element-binding transcription factor. Our results strongly indicate that the O-GlcNAc modification participates in the regulation of CaMKIV activation and function, possibly coordinating nutritional signals with the immune and nervous systems. This is the first example of an O-GlcNAc/phosphate cycle involving O-GlcNAc transferase/kinase cross-talk.
引用
收藏
页码:21327 / 21337
页数:11
相关论文
共 68 条
[11]   The GROMOS software for biomolecular simulation:: GROMOS05 [J].
Christen, M ;
Hünenberger, PH ;
Bakowies, D ;
Baron, R ;
Bürgi, R ;
Geerke, DP ;
Heinz, TN ;
Kastenholz, MA ;
Kräutler, V ;
Oostenbrink, C ;
Peter, C ;
Trzesniak, D ;
Van Gunsteren, WF .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1719-1751
[12]   Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation [J].
Clark, RJ ;
McDonough, PM ;
Swanson, E ;
Trost, SU ;
Suzuki, M ;
Fukuda, M ;
Dillmann, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44230-44237
[13]   Structural insights into mechanism and specificity of O-GlcNAc transferase [J].
Clarke, Andrew J. ;
Hurtado-Guerrero, Ramon ;
Pathak, Shalini ;
Schuttelkopf, Alexander W. ;
Borodkin, Vladimir ;
Shepherd, Sharon M. ;
Ibrahim, Adel F. M. ;
van Aalten, Daan M. F. .
EMBO JOURNAL, 2008, 27 (20) :2780-2788
[14]  
Cohen PTW, 2002, J CELL SCI, V115, P241
[15]   Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine [J].
Comer, FI ;
Vosseller, K ;
Wells, L ;
Accavitti, MA ;
Hart, GW .
ANALYTICAL BIOCHEMISTRY, 2001, 293 (02) :169-177
[16]   Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II [J].
Comer, FI ;
Hart, GW .
BIOCHEMISTRY, 2001, 40 (26) :7845-7852
[17]   Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity [J].
Copeland, Ronald J. ;
Bullen, John W. ;
Hart, Gerald W. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (01) :E17-E28
[18]   Hepatic glucose sensing via the CREB coactivator CRTC2 [J].
Dentin, Renaud ;
Hedrick, Susan ;
Xie, Jianxin ;
Yates, John, III ;
Montminy, Marc .
SCIENCE, 2008, 319 (5868) :1402-1405
[19]   O-GlcNAc modification in diabetes and Alzheimer's disease [J].
Dias, Wagner B. ;
Hart, Gerald W. .
MOLECULAR BIOSYSTEMS, 2007, 3 (11) :766-772
[20]  
Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235